1 / 4

US Influenza Vaccines Market 2023 - 2031

DPI Research has published a new research report titled <br>u201cUnited States Influenza Vaccines Market Size, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2031<br>u201d in its research database.<br><br><br>The influenza vaccines market in the United States was valued at US$ 3,962 million in 2022 and is expected to reach US$ 8,347 million by 2031, registering a CAGR of 8.6% during the forecast period.<br><br>Rapid market expansion is primarily due to increased research and development, the introduction of quadrivalent influenza vaccines, the aging population, and vaccine awareness.

dpiresearch
Download Presentation

US Influenza Vaccines Market 2023 - 2031

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. United States Influenza Vaccines Market 2023 - 2031 The influenza vaccines market in the United States was valued at US$ 3,962 million in 2022 and is expected to reach US$ 8,347 million by 2031, registering a CAGR of 8.6% during the forecast period. Rapid market expansion is primarily due to increased research and development, the introduction of quadrivalent influenza vaccines, the aging population, and vaccine awareness. In addition, expanded recommendations from government and advisory bodies to get influenza vaccines are driving market growth in the United States.

  2. United States Influenza Vaccines Market 2023 - 2031 Influenza is the second leading cause of death from vaccine-preventable disease in the United States after COVID-19. Rates of seasonal influenza infection are highest in children, but the risks for complications, hospitalizations, and deaths are higher in adults 65 years of age and older, children younger than 5 years, pregnant women, and people of any age with conditions that place them at increased complications. risk for influenza

  3. United States Influenza Vaccines Market 2023 - 2031 More Details @ https://dpiresearch.com/united-states-influenza-vaccines-market-2023/ Contact Us: Maria Rai Head of Business Development DPI Research Direct Line: +91-766-764-8693 E-mail: sales@dpiresearch.com

More Related